Consult your doctor or pharmacist before startingtotake this medication:
Stop taking Azitromicina pensa pharmaand visit your doctor immediately if you notice any of the following severe side effects while taking this medication:
Other medications and Azitromicina pensa pharma
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Notify your doctor or pharmacist if you are taking any of the following medications:
Taking Azitromicina pensa pharmawith food and drinks
This medication can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Azitromicina should not be taken during pregnancy or if you plan to become pregnant. It should only be used during pregnancy when clearly necessary.
Do not breastfeed while taking azitromicina, as the risk to the infant cannot be ruled out.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
If the medication causes dizziness or you notice any other side effect that impairs your ability to concentrate, do not drive or operate machinery.
Azitromicina pensa pharmacontains lactose
If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor again.
The tablets should be swallowed preferably with water, they can be taken with or without food.
The groove should not be used to break the tablet.
The recommended dose is:
Adults (including elderly patients) and children over 45 kg of weight:
The recommended dose is 1,500 mg divided over 3 or 5 days in the following way:
Urethral or cervical inflammation caused by Chlamydia:
1,000 mg taken as a single dose, on one day.
Children and adolescents under 45 kg of weight:
The tablets are not indicated for these patients. Other pharmaceutical forms of medications containing azitromicina (e.g. suspensions) may be used.
Patients with renal or hepatic impairments:
Inform your doctor immediately if you have kidney or liver problems as this may require modification of the usual dose.
If you take more Azitromicina pensa pharma than you should
If you (or another person) ingest many tablets together, or if you believe a child has ingested any of the tablets, contact your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount used. It is recommended to bring the packaging and leaflet to the healthcare professional. A overdose may cause reversible hearing loss, intense nausea (sensation of dizziness), vomiting, and diarrhea.
If you forgot to take Azitromicina pensa pharma
Do not take a double dose to compensate for the missed dose.
If you forgot to take a tablet, take it as soon as possible, unless it is almost time for the next dose.
If you interrupt the treatment with Azitromicina pensa pharma
Do not stop taking the medication without consulting your doctor first, even if you feel better. It is essential to continue taking azitromicina for the indicated period of time by your doctor, if not, it is possible that the infection will recur.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Azitromicina pensa pharmacan cause side effects, although not everyone will experience them.
Stop taking Azitromicina pensa pharmaand see your doctor immediately if you notice any of the following serious side effects, as they may require emergency medical treatment:
Other side effects include:
Very common: affects more than 1 in 10 patients |
Common: affects between 1 and 10 in 100 patients |
Uncommon: affects between 1 and 10 in 1,000 patients |
Rare: affects between 1 and 10 in 10,000 patients |
Very rare: affects fewer than 1 in 10,000 patients |
Frequency not known: cannot be estimated from available data |
Very common:
Common:
Uncommon:
Rare:
Frequency not known:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use. Website:www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions. Do not change the tablets to another container.
Do not use this medication after the expiration date that appears on the container, after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
Composition of A azitromicina pensa pharma 500 mg coated tablets
The active ingredient is azitromicina. Each tablet contains 500 mg of azitromicina (as dihydrate of azitromicina).
The other components (excipients) are:
Appearance of the product and contents of the packaging
Azitromicina pensa pharma 500 mg is presented in the form of coated tablets of white color, oblong, biconvex, scored on one side.
The tablets are packaged in unit dose blisters of starch-coated paper and in PVC blisters united to an aluminum foil.
Clinical packaging of 150 tablets in PVC blisters united to an aluminum foil.
Packaging of 3 tablets in PVC blisters united to an aluminum foil.
Packaging containing 3 tablets in unit dose blisters of starch-coated paper.
Unit dose blister of starch-coated paper.
Only some packaging sizes may be marketed.
Marketing authorization holder and responsible manufacturer:
Marketing authorization holder: :
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible manufacturer: :
Bluepharma Industria Farmacêutica S.A.
S.Martinho do Bispo 3045-016
Coimbra
Portugal
or
Sincrofarm, S.L.
C/ Mercurio Nº 10,
Pol. Ind. Almeda, 08940
Cornellá de Llobregat, Barcelona
Spain
Last review date of this leaflet: May 2018
The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.